Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by N00bInvesT0Ron Jun 13, 2020 7:56pm
237 Views
Post# 31147453

RE:RE:RE:Good reading for Due Dilligence

RE:RE:RE:Good reading for Due Dilligence
Vinny57 wrote:
Westboro1 wrote: What really makes Aphria stand-out is the new CEO.  A proven winner  - Irwin's success thorugh his own company Hain Celestial Group and his enabling relationship(s) with the food and berverage industry like Whole Foods says it all.  One of the key factors in regaining the respect of Wall Street was to have professional management. Aphria attracted one of the best in the business, and now will get the management and Wall street support it needs.



You are obviously new to this board.  Simon has done little for this company and us shareholders. He has systematicly crippled the share price every few months for reasons nobody here can figure out.  He has proven to be no better (if not worse) than Vic.

"A proven winner".........I think not!



All the values are in canadian dollar unless stated otherwise


Canopy Growth Corporation

  • Impairment on assets
  • Billions of dollar of Cash Burn but they can afford it
  • No profitability in sight or Ebidta Positive
  • Closing facilities
  • Laying off workers
  • Losing share in the recreational sales
  • 2 B$ Cash on hands
  • Market Cap rounded up 8 B$
  • Fiscal 2019 Revenue 399 M$
  • Market Cap/Yearly Revenue = 20 rounded up
Aurora Cannabis
  • Diluting shareholders to acquire alot of companies (they have like 20+ companies)
  • Diluting shareholders to raise more cash
  • Reverse split to raise more cash 1:12 ratio
  • No profitability on sight
  • Laying off workers
  • Halting construction of new facilities
  • Putting on sale greenhouse
  • 230M cash on hands
  • Market Cap 2B $
  • Fiscal year not over, one quarter left 206 M$ Revenue
  • Unless they surprise the universe they will end the year with a 9-10 ratio

They show hopes of being back on track, they have an increase in recreational revenues, big pump of the share price, they back at diluting shareholders again with an acquisition.

Aphria
  • Ebidta positif 4 quarters in a row
  • Layed off only marketing people
  • Didn't halt construction plans or close any facility
  • Serious contender to reach profitability
  • 515 M Cash on Hands
  • Cash burning like everyone but responsable since Ebidta Positive 4 Q in a row
  • Partial share dilution for cash raise, 100M from a institution that payed more than 7$ a share.
  • Dilution Senior convertibles notes like all the canadian cannabis companies
  • Never reported decrease in recreational sales market in a quarter
  • Reported increase in recreational sales 2 out the last 4 quarters
  •  Market Cap 1.6 B$ Rounded up
  • 391M Revenue and missing 1 more quarter to finish Fiscal 2019
  • We looking at a Market Cap/Yearly Revenue ratio of 4 no Sweat.

 

Now lets compare the share price from January 2019 to today.

Aphria

Share price at high of the month of january 2019 : 11,74 $ / share
Share price at the close of June 12 2020 : 5.88 $ / share
Shareholders today have a return on investment of minus 50%

Canopy Growth


Share price at high of the month of january 2019 : 67,62 $ / share
Share price at the close of June 12 2020 : 22,44 $ / share
Shareholders today have a return on investment of  minus 67%

Aurora Cannabis (If we compare prices without the 1:12 reverse split)

Share price at high of the month of january 2019 : 9.95 $ or 119.40$ / share
Share price at the close of June 12 2020 : 1.49 $ or 17.91$ / share
Shareholders today have a return on investment of  minus 86%


So honestly Vinny, you are sitting on a gold mine right now and Irwin is amazing.
If you are impatient or still feel that it's only Aphria that is taking a hit then I can't enlight you more.

Patience kid and enjoy the free due dilligence that you clearly didn't do.  I just wasted 1 hour to do this post, if anyone has a problem with the numbers, you can go have fun and surf between those 3 companies financials and all the news about Aurora/Weed/Aphria


Enjoy the saturday reading.






 

Bullboard Posts